UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: October 6, 2021
Accession Number: 0001193125-21-292163
Submission Type: POS AM
CIK: 0001346302
Company Name: XERIS PHARMACEUTICALS INC
File Number: 333-233061